Insider Selling: Immunovant, Inc. (NASDAQ:IMVT) CEO Sells $129,609.14 in Stock

Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) CEO Peter Salzmann sold 4,619 shares of the stock in a transaction on Tuesday, July 9th. The shares were sold at an average price of $28.06, for a total value of $129,609.14. Following the completion of the transaction, the chief executive officer now owns 1,032,097 shares in the […]

Leave a Reply

Your email address will not be published.

Previous post Tesla (NASDAQ:TSLA) Rating Reiterated by Oppenheimer
Next post Catalent, Inc. (NYSE:CTLT) CFO Sells $169,822.82 in Stock